Schizophrenia Bulletin

Papers
(The H4-Index of Schizophrenia Bulletin is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disorders263
Self-stigma in Serious Mental Illness: A Systematic Review of Frequency, Correlates, and Consequences107
Implementing Precision Psychiatry: A Systematic Review of Individualized Prediction Models for Clinical Practice94
A Meta-analysis of Cognitive Remediation for Schizophrenia: Efficacy and the Role of Participant and Treatment Factors71
A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse69
COVID-19 Prevalence and Mortality Among Schizophrenia Patients: A Large-Scale Retrospective Cohort Study66
Disparities in Intensive Care Unit Admission and Mortality Among Patients With Schizophrenia and COVID-19: A National Cohort Study65
Cognitive Predictors of Social and Occupational Functioning in Early Psychosis: A Systematic Review and Meta-analysis of Cross-Sectional and Longitudinal Data61
Brief Psychotic Disorder During the National Lockdown in Italy: An Emerging Clinical Phenomenon of the COVID-19 Pandemic57
The Self in the Spectrum: A Meta-analysis of the Evidence Linking Basic Self-Disorders and Schizophrenia56
Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia —Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) W53
Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)47
Large-Scale Evidence for an Association Between Peripheral Inflammation and White Matter Free Water in Schizophrenia and Healthy Individuals46
Geolocation as a Digital Phenotyping Measure of Negative Symptoms and Functional Outcome46
Genome-Wide Association Studies of Schizophrenia and Bipolar Disorder in a Diverse Cohort of US Veterans45
Hierarchical Pathways from Sensory Processing to Cognitive, Clinical, and Functional Impairments in Schizophrenia44
Comorbid Major Depressive Disorder in Schizophrenia: A Systematic Review and Meta-Analysis44
Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders42
Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison41
Association Between Specific Childhood Adversities and Symptom Dimensions in People With Psychosis: Systematic Review and Meta-Analysis40
Digital phenotyping of negative symptoms: the relationship to clinician ratings40
Striatal Dopamine and Reward Prediction Error Signaling in Unmedicated Schizophrenia Patients39
Understanding Language Abnormalities and Associated Clinical Markers in Psychosis: The Promise of Computational Methods38
COVID-19 Infection May Cause Clozapine Intoxication: Case Report and Discussion38
Interrelationships Between BDNF, Superoxide Dismutase, and Cognitive Impairment in Drug-Naive First-Episode Patients With Schizophrenia37
Metabolomic Identification of Exosome-Derived Biomarkers for Schizophrenia: A Large Multicenter Study37
Meta-Analysis of Sensorimotor Gating Deficits in Patients With Schizophrenia Evaluated by Prepulse Inhibition Test37
Using Natural Language Processing on Electronic Health Records to Enhance Detection and Prediction of Psychosis Risk36
Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium36
Antipsychotic-Induced Weight Gain: Dose-Response Meta-Analysis of Randomized Controlled Trials36
Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia36
A White Matter Connection of Schizophrenia and Alzheimer’s Disease33
Comparative Effectiveness of Antipsychotics for Risk of Attempted or Completed Suicide Among Persons With Schizophrenia33
Long-term Continuity of Antipsychotic Treatment for Schizophrenia: A Nationwide Study33
0.034073114395142